Paper Details
- Home
- Paper Details
Transdermal nicotine for active ulcerative colitis.
Author: FeyerabendC, GaneshS, ManiV, MorrisJ S, NewcombeR G, PullanR D, RhodesJ, RussellM A, ThomasG A, WilliamsG T
Original Abstract of the Article :
BACKGROUND: Ulcerative colitis is largely a disease of nonsmokers. Because anecdotal reports suggest that smoking and nicotine may improve the symptoms of the disease, we examined the effect of nicotine as a supplemental treatment for ulcerative colitis. METHODS: We treated 72 patients with active ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1056/NEJM199403243301202
データ提供：米国国立医学図書館（NLM）
Transdermal Nicotine as a Supplemental Treatment for Ulcerative Colitis
Ulcerative colitis, a debilitating inflammatory bowel disease, often affects non-smokers. This study explores the potential benefits of transdermal nicotine as a supplemental treatment for active ulcerative colitis. The authors conducted a randomized, double-blind study to compare the effects of nicotine patches with placebo patches in patients with active ulcerative colitis. The study found that transdermal nicotine improved symptoms in patients with ulcerative colitis, suggesting a potential role for nicotine therapy in managing this condition.
Potential for a Novel Treatment Approach
This research reveals a potentially novel treatment approach for ulcerative colitis. The study suggests that transdermal nicotine can be a valuable supplemental therapy for managing symptoms of the disease. These findings could lead to new treatment strategies for patients with ulcerative colitis, particularly those who are not responding to conventional therapies.
Managing Ulcerative Colitis with Nicotine
This research suggests that transdermal nicotine could be a viable option for managing ulcerative colitis, particularly in combination with other therapies. The study found that nicotine was effective in reducing symptoms and improving overall clinical response in patients with active disease. These findings encourage further investigation into the potential benefits of nicotine therapy for ulcerative colitis, potentially leading to improved treatment outcomes and a better quality of life for patients.
Dr.Camel's Conclusion
This research is like discovering a hidden oasis in the desert of ulcerative colitis treatment. The findings suggest that transdermal nicotine could provide relief for patients struggling with this condition. While further research is needed to fully understand the mechanisms and long-term effects of this therapy, this research offers a promising new path toward improved symptom management and a better quality of life for those affected by ulcerative colitis.
Date :
- Date Completed 1994-03-29
- Date Revised 2015-11-19
Further Info :
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.